Law Street Capital > Lawsuit Funding > Dangerous Drug Lawsuits > Pradaxa Lawsuit Funding

Pradaxa Lawsuit Funding

product liability 1In the wake of increasing dangerous drug lawsuits against pharmaceutical giants Boehringer Ingelheim, pre settlement lawsuit funding is in high demand by former users of the blood thinning drug Pradaxa. In 2011, the FDA received more fatality reports related to Pradaxa than any other drug on the market, and many patients experienced uncontrollable internal bleeding after taking the medication. Individuals who have been injured or lost loved ones resulting from Pradaxa use may be eligible for compensation. At LawStreet Capital, Pradaxa lawsuit funding is available to help you bridge the gap between filing a claim and actually receiving compensation.

FDA warns of Pradaxa risks

According to an FDA MedWatch report conducted earlier this year, Pradaxa caused 542 deaths in 2011 – more than any other drug. Pradaxa also topped the tables for a number of other major health problems, including 2,367 cases of hemorrhaging, 291 cases of acute renal failure and 644 strokes. In Europe, Boehringer Ingelheim must now clearly state the risks of internal bleeding on the labeling.

Pradaxa has been an enormously successful product, racking up sales exceeding $1 billion in 2012, but adverse events reports have plagued the drug manufacturer within months of Pradaxa being released.

The possible dangers of taking Pradaxa are now widely known. Recently, Boehringer Ingelheim was ordered to add stronger warnings about bleeding risks to their labeling in Europe. Nonetheless, the product has been hugely popular as a replacement for Warfarin – commonly known as Coumadin – which has dominated the blood-thinner market for 50 years. Warfarin comes with a long list of side effects that has, until recently, made Pradaxa appear the most attractive of the two.

Possible side effects of Pradaxa

Pradaxa is prescribed to prevent blood clots that form because of atrial fibrillation. Side effects include bruising, bleeding, nausea and abdominal or stomach pain. If it affects the blood proteins that cause coagulation, it can cause serious bleeding. Tell-tale signs of serious internal bleeding include:

  • persistent nosebleeds
  • heavy periods
  • dark urine
  • severe headache
  • dizziness
  • bloody, tarry stools

While all blood thinners can cause internal bleeding, Pradaxa lacks the reversal agents available for rival anti-coagulants. It was first developed to replace the fifty year-old Warfarin, known for its long list of side effects. But internal bleeding caused by Warfarin can be reversed by taking heavy doses of vitamin K. Doctors have noted that once Pradaxa starts causing bleeding, there is virtually nothing they can do to stop it.

Pradaxa vs. Warfarin

Comparative studies of Pradaxa and Warfarin clearly indicate less adverse reactions caused by the latter. According to a recent study, the rate of adverse reactions that led to patients discontinuing treatment with Pradaxa was 21%. For Warfarin, the rate was just 16%. The most common adverse reactions were dyspepsia, nausea, upper abdominal pain, gastrointestinal hemorrhage and diarrhea.

Status of Pradaxa litigation

Owing to the number of lawsuits filed against Boeringer Ingelheim, a number of cases have been consolidated into multidistrict litigation in Illinois federal court. The Pradaxa Product Liability Litigation (MDL 2385) is helping plaintiffs from across the nation seek restitution from the manufacturers.

Product liability cases are often complex, and the legal process can be lengthy and expensive. Plaintiffs may have to wait months or even years before they see any compensation from their claims. LawStreetCapital can provide Pradaxa lawsuit funding to help plaintiffs pay for medical bills and support themselves while their case is being litigated.

Boehringer Ingelheim has recently admitted that Pradaxa-related fatalities are five times more likely than previously admitted. They updated their labeling in April 2012, but central to the ongoing MDL is a charge of negligence, alleging insufficient warnings, design defect, misrepresentation and fraudulent concealment.

Benefits of Pradaxa lawsuit funding

Plaintiffs pursuing Pradaxa lawsuits will incur significant costs along the way. Medical and legal fees can seriously hinder the financial well being of plaintiffs waiting for their cases to resolve. Lost wages as a result of long periods off work only add to the financial pressure facing many plaintiffs. Such strain may unfairly prompt some people to opt for a quick settlement, meaning they will have to accept a lesser amount than they deserve.

Litigation funding from LawStreet Capital can help you maintain financial stability while your attorney pursues a fair and just settlement on your behalf. If your case is strong, and it looks likely that you will receive a court award or settlement, LawStreet Capital can approve drug lawsuit advance funding in as little as 24 hours. This cash advance is based on the anticipated award or settlement in your pending case.

Apply for your cash advance today

With LawStreet Capital’s drug lawsuit funding, we assume all financial risk. If you lose your case or don’t secure a settlement, you owe nothing – so it’s a worry-free agreement. To begin your application with LawStreet Capital, please complete the form to the right and we’ll put you in touch with a representative who can quickly establish if you are eligible for a cash advance on your pending lawsuit. Once Pradaxa lawsuit funding has been approved, we’ll process your advance through an electronic bank transfer or send the funds via overnight mail. To learn more, please call us toll-free at 800-345-8500.